HEADER TRANSFERASE 07-DEC-21 7QG5 TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE INHIBITOR INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 KEYWDS 2 INTERLEUKIN-1 SIGNALING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,G.R.ROBB,S.L.DEGORCE REVDAT 2 31-JAN-24 7QG5 1 REMARK REVDAT 1 04-MAY-22 7QG5 0 JRNL AUTH I.A.CUMMING,S.L.DEGORCE,A.AAGAARD,E.L.BRAYBROOKE,N.L.DAVIES, JRNL AUTH 2 C.R.DIENE,A.J.EATHERTON,H.R.FELSTEAD,S.D.GROOMBRIDGE, JRNL AUTH 3 E.M.LENZ,Y.LI,Y.NAI,S.PEARSON,G.R.ROBB,J.S.SCOTT, JRNL AUTH 4 O.R.STEWARD,C.WU,Y.XUE,L.ZHANG,Y.ZHANG JRNL TITL IDENTIFICATION AND OPTIMISATION OF A PYRIMIDOPYRIDONE SERIES JRNL TITL 2 OF IRAK4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 63 16729 2022 JRNL REFN ESSN 1464-3391 JRNL PMID 35439688 JRNL DOI 10.1016/J.BMC.2022.116729 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 30303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1472 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.20 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3141 REMARK 3 BIN FREE R VALUE : 0.3337 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 25 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4376 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.12910 REMARK 3 B22 (A**2) : -5.93190 REMARK 3 B33 (A**2) : 11.06100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.380 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.369 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.248 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.359 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.248 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4534 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6124 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1608 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 781 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4534 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 583 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3745 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.44 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -16.8378 -30.0679 -16.8363 REMARK 3 T TENSOR REMARK 3 T11: 0.1048 T22: 0.0964 REMARK 3 T33: -0.1175 T12: 0.2059 REMARK 3 T13: 0.014 T23: 0.0413 REMARK 3 L TENSOR REMARK 3 L11: 1.2105 L22: 0.7959 REMARK 3 L33: 4.6468 L12: -0.5797 REMARK 3 L13: -1.1625 L23: 0.6313 REMARK 3 S TENSOR REMARK 3 S11: -0.0608 S12: 0.0496 S13: 0.7959 REMARK 3 S21: 0.0496 S22: 0.0283 S23: 0.5616 REMARK 3 S31: 0.7959 S32: 0.5616 S33: 0.0325 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -56.0908 -25.1688 -15.412 REMARK 3 T TENSOR REMARK 3 T11: 0.0512 T22: 0.0225 REMARK 3 T33: -0.1696 T12: -0.0291 REMARK 3 T13: -0.0065 T23: -0.0802 REMARK 3 L TENSOR REMARK 3 L11: 1.1905 L22: 0.9982 REMARK 3 L33: 3.8787 L12: -0.9071 REMARK 3 L13: -0.7028 L23: 0.2283 REMARK 3 S TENSOR REMARK 3 S11: 0.3476 S12: -0.0696 S13: -0.1115 REMARK 3 S21: -0.0696 S22: -0.1968 S23: -0.2263 REMARK 3 S31: -0.1115 S32: -0.2263 S33: -0.1508 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QG5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292119524. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 12M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30396 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 86.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6RFJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M AMS 0.1 M HEPES PH 7.45, REMARK 280 EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.70000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.19000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.05500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.70000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.19000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.05500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.70000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.19000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.05500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.70000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.19000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.05500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ARG A 164 REMARK 465 SER A 186 REMARK 465 VAL A 187 REMARK 465 GLY A 188 REMARK 465 GLY A 189 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 SER A 253 REMARK 465 ASP A 254 REMARK 465 GLY A 255 REMARK 465 ASP A 256 REMARK 465 ASP A 257 REMARK 465 LEU A 258 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 SER B 336 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 310 CD - NE - CZ ANGL. DEV. = 9.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 184 -152.95 -84.44 REMARK 500 VAL A 205 -81.12 -126.27 REMARK 500 ASN A 207 -2.00 68.76 REMARK 500 ARG A 310 -2.55 76.63 REMARK 500 ASP A 311 49.88 -145.20 REMARK 500 ASP A 320 -169.56 -79.54 REMARK 500 ASP A 329 84.14 61.08 REMARK 500 VAL A 343 133.03 120.21 REMARK 500 LYS A 417 31.61 -87.46 REMARK 500 ASN B 178 70.34 54.56 REMARK 500 ASN B 179 46.14 39.38 REMARK 500 ASP B 181 103.36 -54.58 REMARK 500 ASN B 207 -3.52 69.49 REMARK 500 ASP B 254 30.18 -89.57 REMARK 500 ARG B 310 -1.79 75.63 REMARK 500 ASP B 311 49.10 -145.68 REMARK 500 ASP B 329 86.88 65.68 REMARK 500 LYS B 417 32.74 -88.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 702 DISTANCE = 6.36 ANGSTROMS DBREF 7QG5 A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 7QG5 B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 SEQADV 7QG5 GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 7QG5 GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 A 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 A 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 A 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 A 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 A 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 A 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 A 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 A 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 A 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 A 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 A 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 A 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 A 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 A 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 A 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 A 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 A 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 A 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 A 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 A 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 A 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 A 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 A 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 B 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 B 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 B 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 B 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 B 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 B 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 B 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 B 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 B 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 B 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 B 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 B 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 B 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 B 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 B 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 B 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 B 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 B 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 B 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 B 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 B 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 B 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 B 308 GLN LEU LEU GLN GLU MET THR ALA SER MODRES 7QG5 TPO A 345 THR MODIFIED RESIDUE MODRES 7QG5 SEP A 346 SER MODIFIED RESIDUE MODRES 7QG5 TPO B 345 THR MODIFIED RESIDUE MODRES 7QG5 SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET B7R A 501 35 HET B7R B 501 35 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM B7R 4-[(1-METHYLCYCLOPROPYL)AMINO]-2-[[1-(1- HETNAM 2 B7R METHYLPIPERIDIN-4-YL)PYRAZOL-4-YL]AMINO]-6-PYRIMIDIN- HETNAM 3 B7R 5-YL-PYRIDO[4,3-D]PYRIMIDIN-5-ONE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 B7R 2(C24 H28 N10 O) FORMUL 5 HOH *192(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 GLU A 225 CYS A 240 1 16 HELIX 3 AA3 SER A 269 SER A 275 1 7 HELIX 4 AA4 CYS A 276 THR A 280 5 5 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 LYS A 313 ALA A 315 5 3 HELIX 7 AA7 THR A 351 MET A 355 5 5 HELIX 8 AA8 ALA A 356 GLY A 362 1 7 HELIX 9 AA9 THR A 365 GLY A 383 1 19 HELIX 10 AB1 LEU A 397 ASP A 405 1 9 HELIX 11 AB2 THR A 409 ILE A 414 1 6 HELIX 12 AB3 ASP A 422 LEU A 437 1 16 HELIX 13 AB4 LYS A 440 ARG A 444 5 5 HELIX 14 AB5 ASP A 446 THR A 458 1 13 HELIX 15 AB6 SER B 169 ASN B 175 1 7 HELIX 16 AB7 PRO B 184 GLY B 188 5 5 HELIX 17 AB8 GLU B 225 CYS B 240 1 16 HELIX 18 AB9 SER B 269 SER B 275 1 7 HELIX 19 AC1 CYS B 276 THR B 280 5 5 HELIX 20 AC2 SER B 284 ASN B 305 1 22 HELIX 21 AC3 LYS B 313 ALA B 315 5 3 HELIX 22 AC4 THR B 351 MET B 355 5 5 HELIX 23 AC5 ALA B 356 GLY B 362 1 7 HELIX 24 AC6 THR B 365 GLY B 383 1 19 HELIX 25 AC7 LEU B 397 ASP B 405 1 9 HELIX 26 AC8 THR B 409 ILE B 414 1 6 HELIX 27 AC9 ASP B 422 LEU B 437 1 16 HELIX 28 AD1 LYS B 440 ARG B 444 5 5 HELIX 29 AD2 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 PHE A 251 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 LEU A 260 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 209 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 GLY A 198 TYR A 204 -1 N VAL A 199 O LYS A 214 SHEET 6 AA1 6 LYS A 191 GLY A 195 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 6 HIS B 166 SER B 167 0 SHEET 2 AA3 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA3 6 CYS B 259 VAL B 263 -1 O VAL B 261 N GLY B 250 SHEET 4 AA3 6 THR B 208 LYS B 214 -1 N LYS B 213 O LEU B 260 SHEET 5 AA3 6 VAL B 199 VAL B 205 -1 N VAL B 205 O THR B 208 SHEET 6 AA3 6 LYS B 191 GLU B 194 -1 N GLY B 193 O VAL B 200 SHEET 1 AA4 2 ILE B 317 LEU B 319 0 SHEET 2 AA4 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA5 2 VAL B 343 MET B 344 0 SHEET 2 AA5 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C MET A 344 N TPO A 345 1555 1555 1.34 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.34 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 0.95 CISPEP 2 GLU B 392 PRO B 393 0 0.29 CRYST1 87.400 110.380 142.110 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011442 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009060 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007037 0.00000